InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2025-07-11 00:00:00 ET · period of report 2025-07-09 · accession 0001415889-25-019667 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-07-11 2025-07-09 WGS Feeley Kevin CFO S - Sale+OE $93.00 -5,278 3,392 -61% -$490.9K
D 2025-07-11 2025-07-09 WGS Feeley Kevin CFO M - OptEx $32.67 +1,245 8,670 +17% +$40.7K
D 2025-07-11 2025-07-09 WGS Feeley Kevin CFO M - OptEx $0.00 -1,245 6,228 -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-07-09 S D 5,278 $93.00 3,392 D — — (F2) Following the reported sales and option exercise, in addition to the 3,392 shares of Class A common stock and the option to purchase up to 6,228 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 135,762 shares of Class A common stock and additional options to purchase up to an aggregate of 20,924 shares of Class A common stock, which RSUs and options vest according to their respective terms.
2 Common Class A Common Stock 2025-07-09 M A 1,245 $32.67 8,670 D — —
3 Derivative Employee Stock Option (Right to Buy) 2025-07-09 M D 1,245 $0.00 6,228 D $32.67 · — to 2032-08-31 1,245 Common Stock (F2) Following the reported sales and option exercise, in addition to the 3,392 shares of Class A common stock and the option to purchase up to 6,228 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 135,762 shares of Class A common stock and additional options to purchase up to an aggregate of 20,924 shares of Class A common stock, which RSUs and options vest according to their respective terms. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.